Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
TIE
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
thrombospondin-1 mimetic
(ABT-510) / AbbVie
merestinib
(LY2801653) / Eli Lilly
golvatinib
(E7050) / Eisai
imifoplatin
(PT-112) / Promontory Therap
pegylated endostatin
(M2ES) / Protgen
E7820
/ Eisai
Exherin
(ADH-1) / Fennec Pharma
PAN-90806
/ PanOptica
dalantercept
(ACE-041) / Merck (MSD)
pixatimod
(PG545) / Zucero Therap
razuprotafib subcutaneous
(AKB-9778 SC) / Aadi Biosci
ESK981
/ Esanik Therap
Nerofe
(84AA-API 14AA) / Immune System Key
foslinanib immediate release
(CVM-1118) / TaiRx
iSONEP
(sonepcizumab) / Pfizer, Apollo Endosurgery
nesvacumab
(REGN910) / Regeneron
OCX063
/ OccuRx
Pravitinib
(carboxyamidotriazole orotate) / Tactical Therap
hI-con1
(ICON-1) / Endpoint Health
nesvacumab/aflibercept intravitreal
(REGN 910-3) / Regeneron, Bayer
rebastinib
(DCC-2036) / Deciphera
umedaptanib pegol
(RBM-007) / RIBOMIC
MP0250
/ Molecular Partners
Tempostatin
(halofuginone) / Grunenthal, Akashi Therap
gersizangitide
(AXT107) / Asclepix
nanoencapsulated paclitaxel
(FID-007) / ANP Technologies, Fulgent Genetics
pexmetinib
(ARRY-614) / Pfizer
tivozanib eye drops
(KHK4951) / Kyowa Kirin
AV-001
/ Vasomune Therap, AnGes MG
DTRM-555
/ Zhejiang DTRM Biopharma
OC-10X
/ OcuCure Therap
SYL1801
/ PharmaMar
Versavo
(bevacizumab biosimilar) / Dr. Reddy’s
cambritaxestat
(IOA-289) / iOnctura
curcumin/doxorubicin
(iMX-110) / Immix Biopharma
razuprotafib topical
(AKB-9778 topical) / Aadi Biosci
A6
/ Angstrom
Airuituo
(bevacizumab biosimilar) / Jiangsu Hengrui Pharma
IPP-204106
/ ImmuPharma
L1-10
/ Amgen
lenalidomide
(STAR-LLD SC) / Starton Therap
